P Greene1, L Cote, S Fahn. Show Affiliations » 1. Columbia-Presbyterian Medical Center, New York, New York 10032.
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAntiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useCarbidopa/adverse effectsCarbidopa/therapeutic useClozapine/adverse effectsClozapine/therapeutic useDementia/chemically inducedDementia/drug therapyDementia/psychologyDose-Response Relationship, DrugDrug Administration ScheduleDrug CombinationsFemaleHumansLevodopa/adverse effectsLevodopa/therapeutic useMaleMiddle AgedNeurologic Examination/drug effectsParkinson Disease/drug therapyParkinson Disease/psychologyPsychoses, Substance-Induced/drug therapyPsychoses, Substance-Induced/psychology
Substances: See more » Antiparkinson AgentsDrug Combinationscarbidopa, levodopa drug combinationLevodopaClozapineCarbidopa
Year: 1993 PMID: 8420214
Source DB: PubMed Journal: Adv Neurol ISSN: 0091-3952